News25/Ratings1
News · 26 weeks69-58%
2026-03-012026-08-23
Mix3490d
- SEC Filings19(56%)
- Other13(38%)
- Offering1(3%)
- Leadership1(3%)
Latest news
25 items- SECPicard Medical Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Picard Medical, Inc. (0002030617) (Filer)
- PRPicard Medical Reports Second Quarter 2026 Financial Results-Revenue Increases 39% and Net Loss Decreases 16%- Year-to-Date Revenue Increases 50%, with ~$0.9 Million in Gross Profit TUCSON, Ariz., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC ("SynCardia"), maker of the world’s first and only total artificial heart approved by both the U.S. FDA and Health Canada, today reported financial results for the second quarter ended June 30, 2026. "We are encouraged by the progress reflected in our second-quarter results," said Richard Fang, Interim Chief Executive Officer of Picard Medical. "Revenue growth and the improvement in gross profitability reflect
- SECSEC Form 10-Q filed by Picard Medical Inc.10-Q - Picard Medical, Inc. (0002030617) (Filer)
- SECSEC Form NT 10-Q filed by Picard Medical Inc.NT 10-Q - Picard Medical, Inc. (0002030617) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Picard Medical Inc.SCHEDULE 13G/A - Picard Medical, Inc. (0002030617) (Subject)
- PRPicard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026TUCSON, Ariz., July 31, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) ("Picard" or the "Company"), parent company of SynCardia Systems LLC, today announced a major milestone in the development of its Emperor Total Artificial Heart (Emperor TAH) program following the first public scientific presentation of the integrated Emperor Total Artificial Heart architecture at the 48th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (IEEE EMBC 2026) held July 26-30 in Toronto. Presented by Taha Hasekioglu, Director, Office of the COO & Emperor Program Lead, the poster entitled "The Emperor Total Artificial Heart: A Preliminary Electromechanical Arch
- PRPicard Medical / SynCardia to Present Next-Generation Emperor Total Artificial Heart Technology at IEEE EMBC 2026-First scientific presentation of the Emperor Drive System architecture to the biomedical engineering community- TUCSON, Ariz., July 27, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) ("Picard" or the "Company"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by the U.S. Food and Drug Administration (FDA) and Health Canada, today announced that Taha Hasekioglu, Director, Office of the COO & Emperor Program Lead, will present new engineering insights into the Company’s next-generation Emperor Total Artificial Heart (Emperor TAH) system during the 48th Annual International Conference of the IEEE Engineering in Medicine
- SECPicard Medical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits8-K - Picard Medical, Inc. (0002030617) (Filer)
- PRPicard Medical Receives NYSE American Acceptance of Compliance PlanTUCSON, Ariz., July 27, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world’s first and only total artificial heart approved by both the U.S. FDA and Health Canada, today announced that the NYSE American LLC ("NYSE American") has accepted the Company’s plan to regain compliance with the exchange’s continued listing standards under Sections 1003(a)(i) and (ii) of the NYSE American Company Guide. The acceptance of the Company’s compliance plan allows Picard Medical to continue listing and trading its common stock on the NYSE American under the ticker symbol "PMI" while executing the operati
- SECPicard Medical Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - Picard Medical, Inc. (0002030617) (Filer)
- PRPicard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance-Reverse stock split to support continued compliance with NYSE American continued listing standards- TUCSON, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) (the "Company" or "Picard Medical"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by both the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced that its Board of Directors has approved the implementation of a 1-for-50 reverse stock split of the Company's issued and outstanding common stock (the "Reverse Stock Split"). As disclosed in the Company’s Current Report on Form 8-K filed on July 21, 2026, the Company’s stockhold
- SECPicard Medical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Picard Medical, Inc. (0002030617) (Filer)
- SECSEC Form DEFA14A filed by Picard Medical Inc.DEFA14A - Picard Medical, Inc. (0002030617) (Filer)
- PRArtificial Organs Publishes Independent Commentary on Picard Medical and SynCardia's Emperor Total Artificial Heart ProgramTUCSON, Ariz., July 15, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC ("SynCardia"), maker of the world's first and only total artificial heart approved by the U.S. Food and Drug Administration ("FDA") and Health Canada, today announced the publication of an independent commentary in Artificial Organs examining the Company's next-generation Emperor platform, which combines the Emperor Drive with the SynCardia Total Artificial Heart ("STAH"), and its role in the continued evolution of mechanical heart replacement technology. The article, titled "A New Chapter in the Quest for a Fully Implantable Artifi
- PRPicard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual MeetingTUCSON, Ariz., July 13, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC ("SynCardia"), maker of the world's first total artificial heart approved by both the U.S. Food and Drug Administration and Health Canada, today announced the availability of its pre-recorded presentation in advance of the Company's 2026 Annual Meeting of Stockholders, scheduled for July 17, 2026. The presentation provides stockholders with an overview of the Company's recent business performance, product development progress, manufacturing initiatives, and the proposals to be considered at the Annual Meeting. "Despite recent leader
- SECAmendment: Picard Medical Inc. filed SEC Form 8-K: Financial Statements and Exhibits, Other Events8-K/A - Picard Medical, Inc. (0002030617) (Filer)
- SECSEC Form DEFA14A filed by Picard Medical Inc.DEFA14A - Picard Medical, Inc. (0002030617) (Filer)
- SECSEC Form 425 filed by Picard Medical Inc.425 - Picard Medical, Inc. (0002030617) (Subject)
- SECPicard Medical Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Picard Medical, Inc. (0002030617) (Filer)
- SECSEC Form 425 filed by Picard Medical Inc.425 - Picard Medical, Inc. (0002030617) (Subject)
- SECPicard Medical Inc. filed SEC Form 8-K: Financial Statements and Exhibits8-K - Picard Medical, Inc. (0002030617) (Filer)
- PRPicard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual MeetingTUCSON, Ariz., July 02, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC ("SynCardia"), maker of the world's first total artificial heart approved by both the U.S. Food and Drug Administration and Health Canada, today announced the availability of its pre-recorded presentation in advance of the Company's 2026 Annual Meeting of Stockholders, scheduled for July 17, 2026. The presentation provides stockholders with an overview of the Company's recent business performance, product development progress, manufacturing initiatives, and the proposals to be considered at the Annual Meeting. "Despite recent leader
- SECPicard Medical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Picard Medical, Inc. (0002030617) (Filer)
- SECSEC Form DEF 14A filed by Picard Medical Inc.DEF 14A - Picard Medical, Inc. (0002030617) (Filer)
- PRPicard Medical Announces Leadership TransitionTUCSON, Ariz., June 24, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) ("Picard Medical" or the "Company"), parent company of SynCardia Systems, LLC ("SynCardia"), maker of the world’s first total artificial heart approved by both the U.S. Food and Drug Administration and Health Canada, today announced a leadership transition. Patrick NJ Schnegelsberg has stepped down as Chief Executive Officer and as a member of the Company's Board of Directors, effective June 18, 2026. Mr. Schnegelsberg's departure was not the result of any disagreement with the Company on any matter relating to its operations, policies, or practices. Effective June 18, 2026, the Board appointed Richard Fang,
PMI FAQ
6 questionsWhere does PMI stock trade?
Picard Medical Inc. (PMI) is listed on AMEX.What sector and industry is PMI in?
Picard Medical Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Picard Medical Inc. go public?
Picard Medical Inc. (PMI) completed its IPO in 2025.What are analysts saying about PMI?
Picard Medical Inc. has had 1 recent analyst action on file. The most recent action was from H.C. Wainwright: Neutral on 2026-05-18.What companies are similar to PMI?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare PMI side-by-side with any of them on Quantisnow.How can I track PMI on Quantisnow?
Quantisnow aggregates Picard Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PMI to receive live email and push alerts on every new disclosure.